Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 17, 2007. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure regarding a specific share transaction.
Material Changes
The only material change disclosed is a transaction involving Mr. R M Bondy, who acquired a beneficial interest in 1 Ordinary Share of GlaxoSmithKline plc. The share was purchased under a Personal Equity Plan on April 16, 2007, at a price of GBP 14.72.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or contingencies. It is a compliance notification pursuant to Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: April 16, 2007
- Notification Date: April 17, 2007
- Individual: Mr. R M Bondy
- Transaction Type: Acquisition of 1 Ordinary Share via Personal Equity Plan
- Price: GBP 14.72 per share